Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.
The optimal therapy for visceral leishmaniasis in patients with AIDS is unknown. We describe herein three patients with advanced AIDS and disseminated leishmaniasis who were treated with meglumine antimoniate plus interferon-gamma. The conditions of the three patients rapidly improved, and the therapeutic combination drastically reduced the parasite burden; after administration of antiprotozoal therapy for 4 weeks, cultures of bone marrow were negative for two of the three patients. Interferon-gamma was well tolerated. Because the patients died of other AIDS-related diseases in the months following therapy, the efficacy of the combination of meglumine antimoniate and interferon-gamma for preventing relapses remains unknown.
de Górgolas
M
M
Division of Infectious Diseases, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain.
Castrillo
J M
JM
Fernández Guerrero
M L
ML
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000628:therapy*; D000328:Adult; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D015497:HIV-1; D006801:Humans; D007371:Interferon-gamma / Q000008:administration & dosage*; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008536:Meglumine / Q000008:administration & dosage*; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D007371:Interferon-gamma